Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome
C. Adrie et al., Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome, ANESTHESIOL, 93(2), 2000, pp. 422-430
Citations number
38
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: Inhaled nitric oxide (NO) selectively dilates the pulmonary vas
culature and improves gas exchange in acute respiratory distress syndrome.
Because of the very short half-life of NO, inhaled NO is administered conti
nuously. Intravenous Zaprinast (2-o-propoxyphenyl-8-azapurin-6-one), a cycl
ic guanosine monophosphate phosphodiesterase inhibitor, increases the effic
acy and prolongs the duration of action of inhaled NO in models of acute pu
lmonary hypertension. Its efficacy in lung injury models is uncertain, The
authors hypothesized that the use of intravenous Zaprinast would have simil
ar beneficial effects when used in combination with inhaled NO to improve o
xygenation and dilate the pulmonary vasculature in a diffuse model of acute
lung injury.
Methods: The authors studied two groups of sheep with lung injury produced
by saline lavage. In the first group, 0, 5, 10, and 20 ppm of inhaled NO we
re administered in a random order before and after an intravenous Zaprinast
infusion (2 mg/kg bolus followed by 0.1 mg . kg(-1) . min(-1)). In the sec
ond group, inhaled NO was administered at the same concentrations before an
d after an intravenous infusion of Zaprinast solvent (0.05 M NaOH),
Results: After lavage, inhaled NO decreased pulmonary arterial pressure and
resistance with no systemic hemodynamic effects, increased arterial oxygen
partial pressure, and decreased venous admixture (all P < 0.05). The intra
venous administration of Zaprinast alone decreased pulmonary artery pressur
e but worsened gas exchange (P < 0.05). Zaprinast infusion abolished the be
neficial ability of inhaled NO to improve pulmonary gas exchange and reduce
pulmonary artery pressure (P < 0.05 vs. control),
Conclusions: This study suggests that nonselective vasodilation induced by
intravenously administered Zaprinast at the dose used in our study not only
worsens gas exchange, but also abolishes the beneficial effects of inhaled
NO.